- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Rubicon Research Limited — Updates, 15-04-2026: Press Release
15-04-2026 | 05:25 pm
15-04-2026 | 05:25 pm
Rubicon Research acquires 85% of Arinna Lifesciences for approx. ₹175.92 Cr, entering the Indian CNS market. This expands its chronic therapies portfolio and domestic distribution network. Arinna posted ₹56.7 Cr revenue and ₹9.5 Cr EBITDA in 9MFY26.
No comments yet. Be the first to comment!